期刊文献+

(E)-1-取代苯基-3-[4-((E)-(2-(4-苯基噻唑-2-基)腙)甲基)苯基]-2-丙烯-1-酮的合成及PTP1B抑制活性研究 被引量:1

Synthesis and PTP1B Inhibitory Activity of (E)-1-Substitutedphenyl3-(4-((E)-(2-(4-phenylthiazol-2-yl)hydrazono)methyl)phenyl)prop-2-en-1-ones
原文传递
导出
摘要 蛋白酪氨酸磷酸酶1B(PTP1B)作为胰岛素和瘦素信号转导通路的负调节因子,已成为治疗糖尿病和肥胖症的潜在靶标.为了寻找非磷酸酯类PTP1B抑制剂,设计、合成了一系列(E)-1-取代苯基-3-[4-((E)-(2-(4-苯基噻唑-2-基)腙)甲基)苯基]-2-丙烯-1-酮(4a~4n),并对化合物进行了PTP1B抑制活性测定.结果显示,所有化合物对PTP1B均显示出较强的抑制活性,其中化合物4h活性最佳,IC50为(2.57±0.50)μmol L-1. Abstract Protein tyrosine phosphatase 1B (PTP1B) has recently been identified as new drug target for type II diabetes and obesity due to that it is a negative regulator of the insulin and leptin-signaling pathway. In order to find new nonphospho- nate-based pTyr mimetics, a series of novel (E)-1-phenyl-3-(4-((E)-(2-(4-phenyl-thiazol-2-yl)hydrazono)methyl)phenyl)- prop-2-en-l-one (4a-4n) were designed, synthesized, and evaluated for their PTP1B inhibitory activity. The results demon- strated that all compounds presented potent inhibitory activities against PTP1B, among which compound 4h exhibited most potent with IC50 value of (2.57 ±0.50) μmol·L^-1.
出处 《有机化学》 SCIE CAS CSCD 北大核心 2013年第7期1496-1502,共7页 Chinese Journal of Organic Chemistry
基金 国家自然科学基金(Nos.81160381,81125023)资助项目~~
关键词 PTP1B抑制剂 查尔酮 醛腙 噻唑 PTP 1 B inhibitor chalcone carboxaldehyde hydrazone thiazole
  • 相关文献

参考文献30

  • 1Neel, B. G.; Tonks, N. K. Curr. Opin. CellBioL 1997, 9, 193. 被引量:1
  • 2Hunter, T. Cell2000, 100, 113. 被引量:1
  • 3Tonks, N. K.; Neel, B. G. Curr. Opin. CellBiol. 2001, 13, 182. 被引量:1
  • 4Lee, S.; Wang, Q. Med. Res. Rev. 2007, 27, 553. 被引量:1
  • 5Combs, A. P. J. Med. Chem. 2010, 53, 2333. 被引量:1
  • 6Sparks, R. B.; Polam, P.; Zhu, W.; Crawley, M. L.; Takvorian, A.; McLaughlin, E.; Wei, M.; Ala, P. J.; Gonneville, L.; Taylor, N.; Li, Y.; Wynn, R.; Bum, T. C.; Liu, P. C. C.; Combs, A. P. Bioorg. Med. Chem. Lett. 2007, 17, 736. 被引量:1
  • 7Black, E.; Breed, J.; Breeze, A. L.; Embrey, K.; Garcia, R.; Gero, T. W.; Godfrey, L.; Kenny, P. W.; Morley, A. D.; Minshull, C. A. Bioorg. Med. Chem. Lett. 2005, 15, 2503. 被引量:1
  • 8Stuible, M.; Zhao, L.; Aubry, I.; Schmidt-Arras, D.; Bohmer, F.-D.; Li, C.-J.; Tremblay, M. L. ChemBioChem 2007, 8, 179. 被引量:1
  • 9Zhang, Z. -Y. Annu. Rev. Pharmacol. Toxicol. 2002, 42, 209. 被引量:1
  • 10Combs, A. P.; Yue, E. W.; Bower, M.; Ala, P. J.; Wayland, B.; Douty, B.; Takvorian, A.; Polam, P.; Wasserman, Z.; Zhu, W.; Crawley, M. L.; Pruitt, J.; Sparks, R.; Glass, B.; Modi, D.; McLaughlin, E.; Bostrom, L.; Li, M.; Galya, L.; Blom, K.; Hillman, M.; Gonneville, L.; Reid, B. G.; Wei, M.; Becker-Pasha, M.; Klabe, R.; Huber, R.; Li, Y.; Hollis, G.; Burn, T. C.; Wynn, R.; Liu, P.; Metcalf, B. J. Med. Chem. 2005, 48, 6544. 被引量:1

二级参考文献20

共引文献15

同被引文献1

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部